Showing results (501-510 of 857) with videos related to
Sort By:
Pageof 86
The American Journal of Pathology|March 28, 2006
Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective interventionDaniela Macconi, Mauro Abbate, Marina Morigi, et al.Nature Reviews. Nephrology|December 7, 2018
Estimated GFR: time for a critical appraisalEsteban Porrini, Piero Ruggenenti, Sergio Luis-Lima, et al.International Journal of Molecular Sciences|November 25, 2023
Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular ProtectionMonica Locatelli, Daniela Rottoli, Rayan Mahmoud, et al.JCI Insight|August 10, 2018
SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathyPaola Cassis, Monica Locatelli, Domenico Cerullo, et al.Scientific Reports|May 23, 2020
Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetesMonica Locatelli, Carlamaria Zoja, Cristina Zanchi, et al.Frontiers in Immunology|January 23, 2026
Acetylsalicylic acid disrupts SARS-CoV-2 spike protein glycosylation and selectively impairs binding to ACE2Luca Perico, Alessandra Bovio, Susanna Tomasoni, et al.Scientific Reports|March 27, 2025
PKD1 mutation perturbs morphogenesis in tubular epithelial organoids derived from human pluripotent stem cellsAlexandru Scarlat, Piera Trionfini, Paola Rizzo, et al.International Journal of Molecular Sciences|May 13, 2023
Immunophenotypic Alterations in Adult Patients with Steroid-Dependent and Frequently Relapsing Nephrotic SyndromeFederica Casiraghi, Marta Todeschini, Manuel Alfredo Podestà, et al.The Journal of Clinical Investigation|April 17, 2003
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndromeTamara Manuelian, Jens Hellwage, Seppo Meri, et al.Journal of Ophthalmology|July 15, 2010
Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trialPiero Ruggenenti, Ilian Iliev, Marco Filipponi, et al.Pageof 86